3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
55
Lung Neoplasms
25
Parkinson Disease 4, Autosomal Dominant Lewy Body
24
Squamous Cell Carcinoma of Head and Neck
19
Neoplasms
19
Neoplasm Metastasis
19
Melanoma
18
Colorectal Neoplasms
18
Breast Neoplasms
15
Triple Negative Breast Neoplasms
14
Endometrial Neoplasms
14
Ovarian Neoplasms
11
Carcinoma, Transitional Cell
11
Head and Neck Neoplasms
9
Urinary Bladder Neoplasms
8
Pancreatic Neoplasms
8
Carcinoma, Renal Cell
8
Stomach Neoplasms
5
Recurrence
5
Lymphoma
5
Hodgkin Disease
5
Esophageal Neoplasms
5
Carcinoma
5
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Urogenital Neoplasms
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Neoplasms by Site
3
Fallopian Tube Neoplasms
3
Interventions
Cyclophosphamide
4
fludarabine
3
acalabrutinib
3
pirtobrutinib
2
obinutuzumab
2
ibrutinib
2
Rituximab
2
ricolinostat
1
idelalisib
1
fludarabine phosphate
1
Vincristine
1
Prednisone
1
Mesna
1
Leukapheresis
1
Doxorubicin
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
pembrolizumab
×
30 days
×
Clear all
No trials found.